U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Mon Mar 31 21:23:08 GMT 2025
Edited
by admin
on Mon Mar 31 21:23:08 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
2F6ZF5WYCC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VATREPTACOG ALFA (ACTIVATED)
INN   WHO-DD  
INN  
Preferred Name English
VATREPTACOG ALFA
Common Name English
NN-1731
Code English
NN1731
Code English
VATREPTACOG ALFA (ACTIVATED) [JAN]
Common Name English
Vatreptacog alfa (activated) [WHO-DD]
Common Name English
vatreptacog alfa (activated) [INN]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/12/1030
Created by admin on Mon Mar 31 21:23:08 GMT 2025 , Edited by admin on Mon Mar 31 21:23:08 GMT 2025
Code System Code Type Description
DRUG BANK
DB12409
Created by admin on Mon Mar 31 21:23:08 GMT 2025 , Edited by admin on Mon Mar 31 21:23:08 GMT 2025
PRIMARY
SMS_ID
100000177255
Created by admin on Mon Mar 31 21:23:08 GMT 2025 , Edited by admin on Mon Mar 31 21:23:08 GMT 2025
PRIMARY
FDA UNII
2F6ZF5WYCC
Created by admin on Mon Mar 31 21:23:08 GMT 2025 , Edited by admin on Mon Mar 31 21:23:08 GMT 2025
PRIMARY
NCI_THESAURUS
C152841
Created by admin on Mon Mar 31 21:23:08 GMT 2025 , Edited by admin on Mon Mar 31 21:23:08 GMT 2025
PRIMARY
CAS
897936-89-9
Created by admin on Mon Mar 31 21:23:08 GMT 2025 , Edited by admin on Mon Mar 31 21:23:08 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108322
Created by admin on Mon Mar 31 21:23:08 GMT 2025 , Edited by admin on Mon Mar 31 21:23:08 GMT 2025
PRIMARY
INN
8844
Created by admin on Mon Mar 31 21:23:08 GMT 2025 , Edited by admin on Mon Mar 31 21:23:08 GMT 2025
PRIMARY
From To
1_7 1_12
1_26 1_42
1_158 1_177
1_188 1_216
2_17 2_22
2_50 2_61
2_55 2_70
2_72 2_81
2_91 2_102
2_98 2_112
2_114 2_127
1_110 2_135
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_170
N 2_145
O 2_52
O 2_60
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
ENZYMATIC 3R-HYDROXYLATION [2_63] SITE_SPECIFIC ASP .BETA.-HYDROXY-L-ASPARTIC ACID, ERYTHRO- GDV0MSK2SG
ENZYMATIC GAMMA-CARBOXYLATION [2_6] [2_7] [2_14] [2_16] [2_19] [2_20] [2_25] [2_26] [2_29] [2_35] SITE_SPECIFIC GLU .GAMMA.-CARBOXYGLUTAMIC ACID 16FQV4RZKL
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(ESTIMATED) CHEMICAL
Molecular Formula CHEMICAL